The issue I see is its ~$680k (or over 1/3 of available cash) they have committed to this project initially and there is no detail of if they have had independent qualified experts review the tech/patent as there is no way current management would have any idea with this.
As someone else posted the last two announcements have been incredibly vague.
- Forums
- ASX - By Stock
- QXR
- Amazing volumes
Amazing volumes, page-16
-
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add QXR (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
0.001(8.33%) |
Mkt cap ! $7.215M |
Open | High | Low | Value | Volume |
0.6¢ | 0.7¢ | 0.6¢ | $1.91K | 310K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 3944290 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 1623658 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 3444440 | 0.006 |
12 | 3210000 | 0.005 |
2 | 571428 | 0.004 |
3 | 1800000 | 0.003 |
2 | 1200000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.006 | 168985 | 1 |
0.007 | 1623658 | 6 |
0.008 | 1545800 | 6 |
0.009 | 768000 | 4 |
0.010 | 445996 | 2 |
Last trade - 15.26pm 15/07/2024 (20 minute delay) ? |
Featured News
QXR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online